Pfizer Inc Stock Today
| PFE Stock | USD 24.31 0.34 1.42% |
PerformanceVery Weak
| Odds Of DistressLow
|
Pfizer is trading at 24.31 as of the 24th of June 2025, a 1.42 percent increase since the beginning of the trading day. The stock's lowest day price was 24.11. Pfizer has only a 6 % chance of going through financial distress over the next few years, but has generated negative returns over the last 90 days. Note, on June 9, 2025, Representative Gilbert Cisneros of US Congress acquired under $15k worth of Pfizer Inc's common stock.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 13th of August 2012 | Category Healthcare | Classification Health Care |
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. The company has 5.69 B outstanding shares of which 104.99 M shares are at this time shorted by investors with about 2.27 days to cover. More on Pfizer Inc
Moving against Pfizer Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Pfizer Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Chairman CEO | Albert DVM | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Names | [Pfizer Inc, Pfizer Inc, Pfizer Inc] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NYSE Composite, SP 500 Index, SP 100 Index, SP 100, Dow Jones Composite, NYSE 100 Index, ARCA Pharmaceutical, BETTERINVESTING 100 INDEX, BTRINVSTNG 100 INDEX, Healthcare, Robots And Drones, Health Care, Pharmaceuticals, Drug Manufacturers—General, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Excise Tax Activities | Animal TestingCatholic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsPfizer can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Pfizer's financial leverage. It provides some insight into what part of Pfizer's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pfizer Inc (PFE) is traded on New York Stock Exchange in USA. It is located in 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 and employs 81,000 people. Pfizer is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a total capitalization of 136.28 B. Pfizer Inc runs under Pharmaceuticals sector within Health Care industry. The entity has 5.69 B outstanding shares of which 104.99 M shares are at this time shorted by investors with about 2.27 days to cover.
Pfizer Inc has about 2.85 B in cash with 12.74 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.44.
Check Pfizer Probability Of Bankruptcy
Ownership AllocationPfizer owns a total of 5.69 Billion outstanding shares. Over half of Pfizer's outstanding shares are owned by third-party entities. These third-party entities are typically referred to as corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. Please note that on June 9, 2025, Representative Gilbert Cisneros of US Congress acquired under $15k worth of Pfizer Inc's common stock.
Check Pfizer Ownership Details
Pfizer Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Amundi | 2025-03-31 | 52.1 M | |
| Charles Schwab Investment Management Inc | 2025-03-31 | 48 M | |
| Fisher Asset Management, Llc | 2025-03-31 | 47.4 M | |
| Bank Of New York Mellon Corp | 2025-03-31 | 38.7 M | |
| Ubs Asset Mgmt Americas Inc | 2025-03-31 | 38.7 M | |
| Legal & General Group Plc | 2025-03-31 | 37.1 M | |
| Royal Bank Of Canada | 2025-03-31 | 33.7 M | |
| Jpmorgan Chase & Co | 2025-03-31 | 32.3 M | |
| Amvescap Plc. | 2025-03-31 | 30.3 M | |
| Vanguard Group Inc | 2025-03-31 | 523.2 M | |
| Blackrock Inc | 2025-03-31 | 474.2 M |
Pfizer Historical Income Statement
Pfizer Stock Against Markets
Pfizer Corporate Directors
| Helen Hobbs | Independent Director | Profile | |
| Shantanu Narayen | Lead Independent Director | Profile | |
| James Smith | Independent Director | Profile | |
| Susan DesmondHellmann | Independent Director | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.05) | Dividend Share 1.69 | Earnings Share 1.38 | Revenue Per Share | Quarterly Revenue Growth (0.08) |
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pfizer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.